High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK
Open Access
- 8 March 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 67 (5), 1108-1113
- https://doi.org/10.1093/jac/dks018
Abstract
To determine the proportion of E. coli carrying specific CTX-M extended-spectrum β-lactamase (ESBL) genotypes in a community population of East and North Birmingham. General practice and outpatient stool samples from 732 individuals submitted for examination for faecal pathogens in 2010 were screened for ESBL-producing E. coli using chromogenic agar. Multiplex PCR, denaturing HPLC, DNA sequencing and PFGE were used to determine the CTX-M genotype and clonal subtype. Isolates from people were assigned to ‘Europe’, ‘Middle East/South Asia’ (MESA) or ‘uncategorized’ groups using software to determine probable global origin based on the subject's full name. Prevalence of CTX-M carriage in the sample population was 11.3%. There was a statistically significant difference (P < 0.001) between carriage in the Europe group (8.1%) and the MESA group (22.8%). There was also a higher rate of carriage of CTX-M-15-producing E. coli (P < 0.001) in MESA subjects. The high community carriage rate and the significant difference in carriage between the Europe and MESA subjects may have important consequences for therapy. If the rising trend in carriage of bacteria producing ESBLs continues, guidelines for empirical therapy for patients presenting from the community may need to be modified. The findings also raise the concern that the pattern and routes of spread of CTX-M-15 may be replicated in the future by broader-spectrum β-lactamases, such as New Delhi metallo-β-lactamase (‘NDM-1’).Keywords
This publication has 29 references indexed in Scilit:
- The emerging NDM carbapenemasesTrends in Microbiology, 2011
- Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008European Journal of Clinical Microbiology & Infectious Diseases, 2010
- Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4International Journal of Antimicrobial Agents, 2010
- Molecular Characteristics of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired InfectionsAntimicrobial Agents and Chemotherapy, 2009
- The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: a successful collaborative modelJournal of Antimicrobial Chemotherapy, 2008
- BSAC standardized disc susceptibility testing method (version 7)Journal of Antimicrobial Chemotherapy, 2008
- Prevalence and clonality of extended-spectrum β-lactamases in AsiaClinical Microbiology & Infection, 2008
- Rapid and simple detection of bla CTX−M genes by multiplex PCR assayJournal of Medical Microbiology, 2005
- Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UKJournal of Antimicrobial Chemotherapy, 2004
- Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UKJournal of Antimicrobial Chemotherapy, 2004